Hepatitis E virus: The current scenario

International Journal of Infectious Diseases

Volumn 17, Issue 4, 2013, Pages

  Kumar, Subrat ^a   Subhadra, Subhra ^b   Singh, Bhupinder ^c   Panda, B K ^d  

^a KIIT UNIVERSITY   (India)

^b Pandit Deen Dayal Upadhayay Pashu Chikitsa Vigyan Vishwa Vidyalaya Evum Go Anusandhan Sansthan   (India)

^c UNIVERSITY OF OKLAHOMA   (United States)

^d CENTRAL AVIAN RESEARCH INSTITUTE   (India)

Author keywords

Genotypes; Hepatitis E virus; Severe hepatitis; Viral hepatitis

Indexed keywords

ALANINE AMINOTRANSFERASE; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; DNA VACCINE; GAMMA GLUTAMYLTRANSFERASE; HEPATITIS E VACCINE; HEV 239 VACCINE; IMMUNOGLOBULIN; LIVER ENZYME; PROTEIN ORF2; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASYMPTOMATIC INFECTION; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION; CEREBROSPINAL FLUID; CHRONIC HEPATITIS; DISEASE COURSE; DISEASE SEVERITY; DISEASE TRANSMISSION; DRUG EFFICACY; DRUG SAFETY; ENDEMIC DISEASE; ENZYME BLOOD LEVEL; EPIDEMIC; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; IMMUNOCOMPROMISED PATIENT; INCUBATION TIME; INFECTION CONTROL; LIVER FUNCTION TEST; LIVER INJURY; MOLECULAR BIOLOGY; MOLECULAR PATHOLOGY; OPEN READING FRAME; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VIRUS ISOLATION; WATER CONTAMINATION;

ANIMALS; HEPATITIS E; HEPATITIS E VIRUS; HUMANS; VIRAL VACCINES;

EID: 84875371530     PISSN: 12019712     EISSN: 18783511     Source Type: Journal    
DOI: 10.1016/j.ijid.2012.11.026     Document Type: Review

References (66)

1. Vishwanathan R. Infectious hepatitis in Delhi (1955-1956): a critical study-epidemiology. Indian J Med Res 1957, 45(Suppl 1):1-29.
2. Krawczynski K., Hepatitis E. Hepatology 1993, 17:932-941.
3. Khuroo M.S., Teli M.R., Skidmore S., Sofi M.A., Khuroo M.I. Incidence and severity of viral hepatitis in pregnancy. Am J Med 1981, 70:252-255.
4. Jaiswal S.P., Jain A.K., Naik G., Soni N., Chitnis D.S. Viral hepatitis during pregnancy. Int J Gynaecol Obstet 2001, 72:103-108.
5. Kumar S., Ratho R.K., Chawla Y.K., Chakraborti A. The incidence of sporadic viral hepatitis in North India: a preliminary study. Hepatobiliary Pancreat Dis Int 2007, 6:596-599.
6. Rein D.B., Stevens G.A., Theaker J., Whittenborn J.S., Wiersma S.T. The global burden of hepatitis E virus genotypes 1 and 2 in 2005. Hepatology 2012, 55:988-997.
7. Ahmad I., Holla R.P., Jameel S. Molecular virology of hepatitis E virus. Virus Res 2011, 161:47-58.
8. Okamato H. Hepatitis E virus cell culture models. Virus Res 2011, 161:65-77.
9. Zhu F.C., Zhang J., Zhang X.F., Zhou C., Wang Z.Z., Huang S.J., et al. Efficacy and safety of a recombinant hepatitis E vaccine in healthy adults: a large scale, randomised, double-blind placebo-controlled phase-3 trial. Lancet 2010, 376:895-902.
10. Pudupkam R.S., Kenney S.P., Cordoba L., Huang Y.W., Dryman B.A., Leroith T., et al. Mutational analysis of the hypervariable region of hepatitis E virus reveals its involvement in the efficiency of viral RNA replication. J Virol 2011, 85:10031-10040.
11. Pudupakam R.S., Huang Y.W., Opriessnig T., Halbur P.G., Pierson F.W., Meng X.J. Deletions of the hypervariable region (HVR) in open reading frame 1 of hepatitis E virus do not abolish virus infectivity: evidence for attenuation of HVR deletion mutants in vivo. J Virol 2009, 83:384-395.
12. Tam A.W., Smith M.M., Guerra M.E., Huang C.C., Bradley D.W., Fry K.E., et al. Hepatitis E virus (HEV): molecular cloning and sequencing of the full length viral genome. Virology 1991, 185:120-131.
13. Tsarev S.A., Binn L.N., Gomatos P.J., Arthur R.R., Monier M.K., Cuyck-Gandre H., et al. Phylogenetic analysis of hepatitis E virus isolates from Egypt. J Med Virol 1999, 57:68-74.
14. Huang C.C., Nguyen D., Fernandez J., Yun K.Y., Fry K.E., Bradley D.W., et al. Molecular cloning and sequencing of the Mexico isolate of hepatitis E virus. Virology 1992, 191:550-558.
15. Schlauder G.G., Desai S.M., Zanetti A.R., Tassopoulos N.C., Mushahwar I.K. Novel hepatitis E virus (HEV) isolates from Europe: evidence for additional genotypes of HEV. J Med Virol 1999, 57:243-251.
16. Takahashi M., Nishizawa T., Miyajima H., Gotanda Y., Iita T., Tsuda F., et al. Swine hepatitis E virus strains in Japan form four phylogenetic clusters comparable with those of Japanese isolates of human hepatitis E virus. J Gen Virol 2003, 84:851-862.
17. Takahashi M., Nishizawa T., Okamoto H. Identification of a genotype III swine hepatitis E virus that was isolated from a Japanese pig born in 1990 and that is most closely related to Japanese isolates of human hepatitis E virus. J Clin Microbiol 2003, 41:1342-1343.
18. Wang Y., Ling R., Erker J.C., Zhang H., Li H., Desai S., et al. A divergent genotype of hepatitis E virus in Chinese patients with acute hepatitis. J Gen Virol 1999, 80:169-177.
19. Caron M., Enouf V., Than S.C., Dellamonica L., Buisson Y., Nicand E. Identification of genotype 1 hepatitis E virus in samples from swine in Cambodia. J Clin Microbiol 2006, 44:3440-3442.
20. Hsieh S.Y., Meng X.J., Wu Y.H., Liu S.T., Tam A.W., Lin D.Y., et al. Identity of a novel swine hepatitis E virus in Taiwan forming a monophyletic gr oup with Taiwan isolates of human hepatitis E virus. J Clin Microbiol 1999, 37:3828-3834.
21. Okamoto H., Takahashi M., Nishizawa T., Fukai K., Muramatsu U., Yoshikawa A. Analysis of the complete genome of indigenous swine hepatitis E virus isolated in Japan. Biochem Biophys Res Commun 2001, 289:929-936.
22. Geng J., Wang L., Wang X., Fu H., Bu Q., Zhu Y., et al. Study on prevalence and genotype of hepatitis E virus isolated from Rex Rabbits in Beijing, China. J Viral Hepat 2011, 18:661-667.
23. Zhao C., Ma Z., Harrison T.J., Feng R., Qiao Z., Fan J., et al. A novel genotype of hepatitis E virus prevalent among farmed rabbits in China. J Med Virol 2009, 81:1371-1379.
24. Johne R., PlengeBönig A., Hess M., Ulrich R.G., Rettz J., Schielke A. Detection of a novel hepatitis E like virus in faeces of wild rats using a nested broad spectrum RTPCR. J Gen Virol 2010, 91:750-758.
25. Takahashi M., Nishizawa T., Sato H., Sato Y., Jirintai Nagashima S., Okamoto H. Analysis of the full length genome of a hepatitis E virus isolate obtained from a wild boar in Japan that is classifiable into a novel genotype. J Gen Virol 2011, 92:902-908.
26. Isaacson M., Fean J., He J., Seriwatana J., Innis B.L. An outbreak of hepatitis E in Northern Namibia, 1983. Am J Trop Dis 2000, 62:619-625.
27. Mast E.E., Purdy M.A., Krawczynski K., Hepatitis E. Baillieres Clin Gastroenterol 1996, 10:227-242.
28. Al-Nasrawi K.K., Al Diwan J.K., Al-Hadithi T.S., Saleh A.M. Viral hepatitis E outbreak in Al-Sadr city, Baghdad, Iraq. East Mediterr Health J 2010, 16:1128-1132.
29. Boccia D., Guthmann J.P., Klovstad H., Hamid N., Tatay M., Ciglenecki I., et al. High mortality associated with an outbreak of hepatitis E among displaced persons in Darfur, Sudan. Clin Infect Dis 2006, 42:1679-1684.
30. Aggarwal R., Kamili S., Spelbring J., Krawczynski E. Experimental studies on sub-clinical hepatitis E virus infection in cynomolgus macaques. J Infect Dis 2001, 184:1380-1385.
31. Kumar S., Pujhari S.K., Chawala Y., Chakraborti A., Ratho R.K. Molecular detection and sequence analysis of hepatitis E virus in patients with viral hepatitis from North India. Diag Microbiol Infect Dis 2011, 71:110-117.
32. Pischke S., Suneetha P.V., Baechlein C., Barg-Hock H., Heim E., Kamar N., et al. Hepatitis E virus infection as a cause of graft hepatitis in liver transplant recipients. Liver Transpl 2010, 16:74-82.
33. Kamar N., Bendall R.P., Peron J.M., Cintas P., Prudhomme L., Mansuy J.M., et al. Hepatitis E virus and neurologic disorders. Emerg Infect Dis 2011, 17:173-179.
34. Kamar N., Izopet J., Cintas P., Garrouste C., Uro-Coste E., Cointault O., et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant 2010, 10:1321-1324.
35. Gerolami R., Moal V., Colson P. Chronic hepatitis E with cirrhosis in a kidney-transplant recipient. N Engl J Med 2008, 358:859-860.
36. Kamar N., Rostaing L., Abravanel F., Garrouste C., Esposito L., Cardeau-Desangles I., et al. Pegylated interferon-alpha for treating chronic HEV infection after liver transplant. Clin Infect Dis 2010, 50:30-33.
37. Kamar N., Abravanel F., Garrouste C., Cardeau-Desangles I., Mansuy J.M., Weclawiak H., et al. Three-month pegylated interferon-alpha-2a therapy for chronic hepatitis E virus infection in a haemodialysis patient. Nephrol Dial Transplant 2010, 25:2792-2795.
38. Kamar N., Rostaing L., Abravanel F., Garrouste C., Sebastien L., Esposito L., et al. Ribavirin therapy inhibits viral replication on patients with chronic HEV infection. Gastroenterology 2010, 139:1612-1618.
39. Dalton H.R., Keane F.E., Bendall R., Mathew J., Ijaz S. Treatment of chronic hepatitis E in a patient with HIV infection. Ann Intern Med 2011, 155:479-480.
40. Gerolami R., Borentain P., Raissouni F., Motte A., Solas C., Colson P. Treatment of severe acute hepatitis E by ribavirin. J Clin Virol 2011, 52:60-62.
41. Tsarev S.A., Emerson S.U., Reyes G.R., Tsareva T.S., Legters L.J., Malik I.A., et al. Characterization of a prototype strain of hepatitis E virus. Proc Natl Acad Sci U S A 1992, 89:559-563.
42. Aggarwal R., Naik S.R. Hepatitis E: does person to person spread occur?. Indian J Gastroenterol 1992, 11:109-112.
43. Mushahwar I.K. HEV: molecular virology, clinical features, diagnosis, transmission, epidemiology and prevention. J Med Virol 2008, 80:646-658.
44. Baylis S.A., Koc O., Nick S., Blumel J. Widespread distribution of hepatitis E virus in plasma fractionation pools. Vox Sang 2012, 102:182-183.
45. Montella F., Rezza G., Sora F.D., Pezzoti P., Recchia O. Association between hepatitis E virus and HIV infection in homosexual men. Lancet 1994, 344:1433.
46. Fainboim H., González J., Fassio E., Martínez A., Otegui L., Eposto M., et al. Prevalence of hepatitis viruses in an anti-human immunodeficiency virus-positive population from Argentina. A multicentre study. J Viral Hepat 1999, 6:53-57.
47. Bali S., Ratho R.K., Kumar S., Singh A. Transmission of hepatitis E in a gr oup of homosexuals in a village of North India. The Internet Journal of Epidemiology 2006, 3(2).
48. Yu Y., Sun J., Liu M., Xia L., Zhao C., Harrison T.J., et al. Seroepidemiology and genetic characterization of hepatitis E virus in the northeast of China. Infect Genet Evol 2009, 9:554-561.
49. Kuniholm M.H., Purcell R.H., McQuillan G.M., Engle R.E., Wasley A., Nelson K.E. Epidemiology of hepatitis E virus in the United States: results from the Third National Health and Nutrition Examination Survey, 1988-1994. J Infect Dis 2009, 200:48-56.
50. Lewis H.C., Wichmann O., Duizer E. Transmission routes and risk factors for autochthonous hepatitis E virus infection in Europe: a systematic review. Epidemiol Infect 2010, 138:145-166.
51. Teo C.G. Much meat, much malady: changing perceptions of the epidemiology of hepatitis E. Clin Microbiol Infect 2010, 16:24-32.
52. Yazaki Y., Mizuo H., Takahashi M., Nishizawa T., Sasaki N., Gotanda Y., et al. Sporadic acute or fulminant hepatitis E in Hokkaido, Japan, may be foodborne, as suggested by the presence of hepatitis E virus in pig liver as food. J Gen Virol 2003, 84:2351-2357.
53. Tai A.L., Cheng P.K., Ip S.M., Wong R.M., Lim W.W. Molecular epidemiology of hepatitis E virus in Hong Kong. J Med Virol 2009, 81:1062-1068.
54. Takahashi K., Kitajima N., Abe N., Mishiro S. Complete or near complete nucleotide sequences of hepatitis E virus genome recovered from a wild boar, a deer, and four patients who ate the deer. Virology 2004, 330:505-510.
55. Li T.C., Chijiwa K., Sera N., Ishibashi T., Etoh Y., Shinohara Y., et al. Hepatitis E virus transmission from wild boar meat. Emerg Infect Dis 2005, 11:1958-1960.
56. Kang J.H., Matsui T., Saga A., Akaike J., Ohmura T., Karino Y., et al. Hepatitis E epidemic in Sapporo area by single source strain of HEV genotype 4. Kanzo 2010, 51:51-53.
57. Yazaki H., Hirano H., Tomital K., Funakoshil I., Koyama Z.I., Okazawa R., et al. Five cases of sporadic hepatitis E at Hokkaido Kitami City in Japan. Nippon Naika Gakkai Zasshi 2006, 95:2295-2297.
58. Drobeniuc J., Meng J., Reuter G., Greene-Montfort T., Khudyakova N., Dimitrova Z., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis 2010, 51:e24-e27.
59. Madej R.M., Davis J., Holden M.J., Kwang S., Labourier E., Schneider G.J. Internal standards and reference materials for quantitative molecular infectious disease testing. J Mol Diagn 2011, 12:133-143.
60. Baylis S.A., Hanschmann K.M., Blumel J., Nubling C.M. Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol 2011, 49:1234-1239.
61. Khuroo M.S., Dar M.Y. Hepatitis E: evidence for person to person transmission and inability of low dose immune serum globulin from Indian source to prevent it. Indian J Gasteroenterol 1992, 11:113-116.
62. Arankalle V.A., Chadha M.S., Dama B.M., Tsarev S.A., Purcell R.H., Banerjee K. Role of immune serum globulins in pregnant women during an epidemic of hepatitis E. J Viral Hepat 1998, 5:199-204.
63. Purcell R.H., Nguyen H., Shapiro M., Engle R.E., Govindarajan S., Blackwelder W.C., et al. Pre-clinical immunogenicity and efficacy trial of a recombinant hepatitis E vaccine. Vaccine 2003, 21:2607-2615.
64. Shrestha M.P., Scott R.M., Joshi D.M., Mammen M.P., Thapa G.B., Thapa N., et al. Safety and efficacy of a recombinant hepatitis E vaccine. N Engl J Med 2007, 356:895-903.
65. Li S.W., Zhang J., Li Y.M., Ou S.H., Huang G.Y., He Z.Q., et al. A bacterially expressed particulate hepatitis E vaccine: antigenicity, immunogenicity and protectivity on primates. Vaccine 2005, 23:2893-2901.
66. Zhang J., Liu C.B., Li R.C., Li Y.M., Zheng Y.J., Li Y.P., et al. Randomized controlled phase II clinical trial of a bacterially expressed recombinant hepatitis E vaccine. Vaccine 2009, 27:1869-1874.